Patient P-01508

Synthetic patientNBL-101 · Day 113 · 35–44 · F · baseline S18Steering view · 3D Open companion preview

Therapy response

Declining

Tolerance

Improving

GI state

Favorable

Inflammatory state

Favorable

Nutritional resilience

Declining

Discontinuation risk

21%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 NBL-101 started — Baseline state S18

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Toxicity-8
Nutritional resilience-6
Inflammatory activity-2

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden

Companion

29.2/100

stable · -1.2 vs previous 14 d

Toxicity

Blood

19.7/100

stable · +0.2 vs previous 14 d

Sleep quality

Wearable

27.5/100

worsening · -3.0 vs previous 14 d

Energy level

Daily log

5.6/10

worsening · -0.3 vs previous 14 d

Stress level

Daily log

4.8/10

stable · -0.1 vs previous 14 d

Steps

Wearable

3,780

worsening · -285 vs previous 14 d

Adherence

Companion

89.8 %

worsening · -5.9 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 68 from the failing basin, 19 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.

Would not help

HY-01 Hydration Protocol
only 40% improved among 10 similar
Keep alcohol low
GI +3.1 next day on high-intake days · n 21

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Alcohol
+3.1detractor · 80%
Insoluble fibre
-2.1no signal · 36%
Dietary fat load
+0.8no signal · 16%
Spicy / capsaicin
+0.5no signal · 15%
Simple carbohydrates
-0.4no signal · 15%
Histamine load
+0.2no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Mucosal barrier integrity ↓40
- MicrobiomeAkkermansia low → thinner mucus layer
- WearableSleep 6.0 h, below personal baseline
Autonomic recovery ↑40
- Wearable3,780 steps/day
- WearableShort sleep window
Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion

DNA

Fictional pharmacogenomic panel

CYP2D6 Normal metabolizer
Expected exposure

Microbiome

Shannon diversity 4.1 · butyrate capacity 53/100

Akkermansia muciniphilaLow
Faecalibacterium prausnitziiLow
Bacteroides fragilisHigh
Bifidobacterium longumNormal
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 36 ms
Sleep: 6.2 h
Steps: 3,871
Resting HR: 61 bpm

Daily log: GI score 29, nutritional resilience 58, adherence 90.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
A 15-minute walk after lunch
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-01804	47%	S19	AD-05	improved	61
P-01541	31%	S09	AD-05	no change	43
P-01377	29%	S11	AD-05	no change	42
P-01329	33%	S08	BR-03	improved	79
P-01689	32%	S13	BR-03	no change	50
P-01677	31%	S05	BR-03	no change	86
P-01495	30%	S07	BR-03	improved	85
P-01430	42%	S05	CR-01	improved	54
P-01654	31%	S08	CR-01	improved	85
P-01371	29%	S06	CR-01	improved	63
P-01767	50%	S14	DT-01	no change	63
P-01724	36%	S10	DT-01	improved	63